115 related articles for article (PubMed ID: 38224097)
1. Lamin B1: a novel biomarker in adult and pediatric adrenocortical carcinoma.
Chen Y; Chen J; Shi Y; Ling X; Fang S; Zhong C; Liu F; Zhong W; Bi X; Dong Z; Lu J
Endocr Relat Cancer; 2024 Mar; 31(3):. PubMed ID: 38224097
[TBL] [Abstract][Full Text] [Related]
2. A pan-cancer analysis based on weighted gene co-expression network analysis identifies the biomarker utility of lamin B1 in human tumors.
Hua Y; He Z; Zhang X
Cancer Biomark; 2022; 34(1):23-39. PubMed ID: 34511484
[TBL] [Abstract][Full Text] [Related]
3. Identification and validation of a tumor mutation burden-related signature combined with immune microenvironment infiltration in adrenocortical carcinoma.
Luo Y; Chen Q; Lin J
Math Biosci Eng; 2022 May; 19(7):7055-7075. PubMed ID: 35730296
[TBL] [Abstract][Full Text] [Related]
4. Tumor mutational burden presents limiting effects on predicting the efficacy of immune checkpoint inhibitors and prognostic assessment in adrenocortical carcinoma.
Xu F; Guan Y; Zhang P; Xue L; Ma Y; Gao M; Chong T; Ren BC
BMC Endocr Disord; 2022 May; 22(1):130. PubMed ID: 35568842
[TBL] [Abstract][Full Text] [Related]
5. Ferroptosis Biomarkers for Predicting Prognosis and Immunotherapy Efficacy in Adrenocortical Carcinoma.
Shen C; Wang Y
Arch Med Res; 2023 Jan; 54(1):45-55. PubMed ID: 36528469
[TBL] [Abstract][Full Text] [Related]
6. Lamin B1 is a potential therapeutic target and prognostic biomarker for hepatocellular carcinoma.
Yang Y; Gao L; Chen J; Xiao W; Liu R; Kan H
Bioengineered; 2022 Apr; 13(4):9211-9231. PubMed ID: 35436411
[TBL] [Abstract][Full Text] [Related]
7. Analysis of m6A-Related Signatures in the Tumor Immune Microenvironment and Identification of Clinical Prognostic Regulators in Adrenocortical Carcinoma.
Jin Y; Wang Z; He D; Zhu Y; Hu X; Gong L; Xiao M; Chen X; Cheng Y; Cao K
Front Immunol; 2021; 12():637933. PubMed ID: 33746977
[TBL] [Abstract][Full Text] [Related]
8. Screening and identification of LMNB1 and DLGAP5, two key biomarkers in gliomas.
Zhou D; Wang M; Zhang Y; Wang K; Zhao M; Wang Y; Wang X; Yu R; Zhou X
Biosci Rep; 2021 May; 41(5):. PubMed ID: 33956061
[TBL] [Abstract][Full Text] [Related]
9. Discovery of a glucocorticoid receptor (GR) activity signature correlates with immune cell infiltration in adrenocortical carcinoma.
Wu K; Liu Z; Liang J; Zhu Y; Wang X; Li X
J Immunother Cancer; 2023 Oct; 11(10):. PubMed ID: 37793855
[TBL] [Abstract][Full Text] [Related]
10. Lamin B1 promotes tumor progression and metastasis in primary prostate cancer patients.
Luo F; Han J; Chen Y; Yang K; Zhang Z; Li J
Future Oncol; 2021 Feb; 17(6):663-673. PubMed ID: 33112662
[No Abstract] [Full Text] [Related]
11. A novel tumor mutational burden-based risk model predicts prognosis and correlates with immune infiltration in ovarian cancer.
Wang H; Liu J; Yang J; Wang Z; Zhang Z; Peng J; Wang Y; Hong L
Front Immunol; 2022; 13():943389. PubMed ID: 36003381
[TBL] [Abstract][Full Text] [Related]
12. Identification of Molecular Subtypes and Prognostic Characteristics of Adrenocortical Carcinoma Based on Unsupervised Clustering.
Zhang Y; Zhang C; Li K; Deng J; Liu H; Lai G; Xie B; Zhong X
Int J Mol Sci; 2023 Oct; 24(20):. PubMed ID: 37895143
[TBL] [Abstract][Full Text] [Related]
13. Identification of an immune-related gene signature as a prognostic target and the immune microenvironment for adrenocortical carcinoma.
Xu C; Qin C; Jian J; Peng Y; Wang X; Chen X; Wu D; Song Y
Immun Inflamm Dis; 2022 Sep; 10(9):e680. PubMed ID: 36039643
[TBL] [Abstract][Full Text] [Related]
14. Identification of NDRG Family Member 4 (NDRG4) and CDC28 Protein Kinase Regulatory Subunit 2 (CKS2) as Key Prognostic Genes in Adrenocortical Carcinoma by Transcriptomic Analysis.
Yang Z; Cheng H; Zhang Y; Zhou Y
Med Sci Monit; 2021 Mar; 27():e928523. PubMed ID: 33667214
[TBL] [Abstract][Full Text] [Related]
15. Lamin B1 overexpression alters chromatin organization and gene expression.
Kaneshiro JM; Capitanio JS; Hetzer MW
Nucleus; 2023 Dec; 14(1):2202548. PubMed ID: 37071033
[TBL] [Abstract][Full Text] [Related]
16. A large genomic deletion leads to enhancer adoption by the lamin B1 gene: a second path to autosomal dominant adult-onset demyelinating leukodystrophy (ADLD).
Giorgio E; Robyr D; Spielmann M; Ferrero E; Di Gregorio E; Imperiale D; Vaula G; Stamoulis G; Santoni F; Atzori C; Gasparini L; Ferrera D; Canale C; Guipponi M; Pennacchio LA; Antonarakis SE; Brussino A; Brusco A
Hum Mol Genet; 2015 Jun; 24(11):3143-54. PubMed ID: 25701871
[TBL] [Abstract][Full Text] [Related]
17. CENPF/CDK1 signaling pathway enhances the progression of adrenocortical carcinoma by regulating the G2/M-phase cell cycle.
Huang YG; Li D; Wang L; Su XM; Tang XB
J Transl Med; 2022 Feb; 20(1):78. PubMed ID: 35123514
[TBL] [Abstract][Full Text] [Related]
18. Identification of immune-related biomarkers in adrenocortical carcinoma: Immune-related biomarkers for ACC.
Peng Y; Song Y; Ding J; Li N; Zhang Z; Wang H
Int Immunopharmacol; 2020 Nov; 88():106930. PubMed ID: 32919215
[TBL] [Abstract][Full Text] [Related]
19. Tumor Mutation Burden, Immune Cell Infiltration, and Construction of Immune-Related Genes Prognostic Model in Head and Neck Cancer.
Jiang AM; Ren MD; Liu N; Gao H; Wang JJ; Zheng XQ; Fu X; Liang X; Ruan ZP; Tian T; Yao Y
Int J Med Sci; 2021; 18(1):226-238. PubMed ID: 33390791
[No Abstract] [Full Text] [Related]
20. Bioinformatic analyses and experimental validation of the role of m6A RNA methylation regulators in progression and prognosis of adrenocortical carcinoma.
Xu F; Guan Y; Ma Y; Xue L; Zhang P; Yang X; Chong T
Aging (Albany NY); 2021 Apr; 13(8):11919-11941. PubMed ID: 33952721
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]